Susan Apkon
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 22 | 2025 | 89 | 5.200 |
Why?
| | Osteoporosis | 5 | 2014 | 243 | 1.280 |
Why?
| | Spinal Muscular Atrophies of Childhood | 2 | 2018 | 17 | 1.020 |
Why?
| | Orthopedic Procedures | 2 | 2019 | 216 | 1.000 |
Why?
| | Bone Density | 6 | 2014 | 489 | 0.970 |
Why?
| | Exercise Therapy | 4 | 2019 | 443 | 0.860 |
Why?
| | Neuromuscular Diseases | 2 | 2025 | 132 | 0.770 |
Why?
| | Myotonic Dystrophy | 1 | 2022 | 10 | 0.740 |
Why?
| | Morpholinos | 1 | 2019 | 30 | 0.610 |
Why?
| | Inpatients | 4 | 2016 | 500 | 0.560 |
Why?
| | Disease Management | 3 | 2020 | 628 | 0.550 |
Why?
| | Musculoskeletal Diseases | 1 | 2018 | 78 | 0.550 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 33 | 0.530 |
Why?
| | Pandemics | 3 | 2020 | 1639 | 0.530 |
Why?
| | Physical Therapy Modalities | 2 | 2017 | 308 | 0.520 |
Why?
| | Alaska Natives | 2 | 2016 | 150 | 0.510 |
Why?
| | Spinal Dysraphism | 3 | 2025 | 90 | 0.500 |
Why?
| | Child | 30 | 2025 | 21935 | 0.490 |
Why?
| | Rehabilitation | 1 | 2016 | 19 | 0.490 |
Why?
| | Myelitis | 1 | 2017 | 107 | 0.480 |
Why?
| | Walking | 2 | 2023 | 529 | 0.470 |
Why?
| | Pediatrics | 2 | 2025 | 1101 | 0.460 |
Why?
| | Occupational Therapy | 1 | 2017 | 100 | 0.460 |
Why?
| | Muscle Spasticity | 2 | 2016 | 58 | 0.440 |
Why?
| | Recovery of Function | 6 | 2019 | 653 | 0.420 |
Why?
| | Physical and Rehabilitation Medicine | 2 | 2025 | 33 | 0.420 |
Why?
| | Primary Health Care | 3 | 2018 | 1738 | 0.410 |
Why?
| | Cerebral Palsy | 2 | 2016 | 107 | 0.390 |
Why?
| | Terminal Care | 1 | 2016 | 232 | 0.390 |
Why?
| | Lumbosacral Region | 1 | 2012 | 58 | 0.390 |
Why?
| | Fractures, Bone | 2 | 2015 | 380 | 0.390 |
Why?
| | Healthcare Disparities | 2 | 2016 | 654 | 0.390 |
Why?
| | Parents | 1 | 2021 | 1347 | 0.380 |
Why?
| | Neural Tube Defects | 1 | 2012 | 64 | 0.380 |
Why?
| | Muscular Dystrophies | 2 | 2012 | 36 | 0.370 |
Why?
| | Humans | 53 | 2025 | 137585 | 0.370 |
Why?
| | Social Determinants of Health | 2 | 2025 | 267 | 0.350 |
Why?
| | Femur | 1 | 2012 | 254 | 0.340 |
Why?
| | Anti-Dyskinesia Agents | 1 | 2010 | 6 | 0.330 |
Why?
| | Critical Illness | 1 | 2016 | 811 | 0.320 |
Why?
| | Botulinum Toxins | 1 | 2010 | 41 | 0.320 |
Why?
| | Neuromuscular Agents | 1 | 2010 | 35 | 0.320 |
Why?
| | Muscular Atrophy, Spinal | 2 | 2020 | 22 | 0.310 |
Why?
| | Diphosphonates | 2 | 2015 | 66 | 0.300 |
Why?
| | Brain Injuries, Traumatic | 3 | 2021 | 360 | 0.300 |
Why?
| | Caregivers | 4 | 2024 | 877 | 0.300 |
Why?
| | Decision Making | 1 | 2016 | 900 | 0.300 |
Why?
| | Delivery of Health Care | 2 | 2022 | 951 | 0.290 |
Why?
| | Alendronate | 1 | 2008 | 15 | 0.290 |
Why?
| | Oligonucleotides | 2 | 2020 | 148 | 0.280 |
Why?
| | Meningomyelocele | 1 | 2008 | 59 | 0.280 |
Why?
| | Bone Density Conservation Agents | 1 | 2008 | 80 | 0.270 |
Why?
| | Rehabilitation Centers | 2 | 2016 | 39 | 0.240 |
Why?
| | Down Syndrome | 1 | 2012 | 496 | 0.240 |
Why?
| | Male | 27 | 2025 | 67762 | 0.220 |
Why?
| | Certification | 1 | 2025 | 113 | 0.220 |
Why?
| | Prednisone | 2 | 2021 | 240 | 0.210 |
Why?
| | Adolescent | 15 | 2025 | 21513 | 0.210 |
Why?
| | Angelman Syndrome | 1 | 2023 | 11 | 0.210 |
Why?
| | Health Services Accessibility | 2 | 2024 | 986 | 0.200 |
Why?
| | Global Health | 2 | 2020 | 386 | 0.200 |
Why?
| | Self-Management | 1 | 2025 | 176 | 0.200 |
Why?
| | Injections, Spinal | 2 | 2020 | 105 | 0.200 |
Why?
| | Child, Preschool | 12 | 2024 | 11074 | 0.190 |
Why?
| | Emergency Medical Services | 2 | 2018 | 552 | 0.190 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1587 | 0.180 |
Why?
| | Codon, Nonsense | 1 | 2021 | 44 | 0.180 |
Why?
| | Cone-Beam Computed Tomography | 2 | 2020 | 39 | 0.180 |
Why?
| | Comorbidity | 3 | 2020 | 1622 | 0.180 |
Why?
| | Medicine | 1 | 2022 | 121 | 0.170 |
Why?
| | Lumbar Vertebrae | 2 | 2016 | 246 | 0.170 |
Why?
| | Florida | 1 | 2021 | 107 | 0.170 |
Why?
| | Executive Function | 1 | 2025 | 451 | 0.170 |
Why?
| | Neoplasms | 1 | 2015 | 2671 | 0.170 |
Why?
| | Absorptiometry, Photon | 2 | 2014 | 259 | 0.170 |
Why?
| | Glucocorticoids | 1 | 2025 | 594 | 0.170 |
Why?
| | Female | 21 | 2025 | 73304 | 0.160 |
Why?
| | Retrospective Studies | 11 | 2022 | 15657 | 0.160 |
Why?
| | Education, Special | 1 | 2020 | 23 | 0.160 |
Why?
| | Indians, North American | 2 | 2016 | 643 | 0.160 |
Why?
| | Schools | 2 | 2021 | 461 | 0.160 |
Why?
| | Intubation, Intratracheal | 1 | 2022 | 257 | 0.160 |
Why?
| | Movement | 1 | 2021 | 278 | 0.150 |
Why?
| | Orthotic Devices | 1 | 2018 | 23 | 0.150 |
Why?
| | Endocrine System | 1 | 2018 | 20 | 0.140 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 57 | 0.140 |
Why?
| | Behavioral Symptoms | 1 | 2018 | 42 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2828 | 0.140 |
Why?
| | Spinal Cord | 1 | 2020 | 370 | 0.140 |
Why?
| | Clinical Competence | 1 | 2025 | 1118 | 0.140 |
Why?
| | Postoperative Care | 1 | 2019 | 261 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.130 |
Why?
| | Neurological Rehabilitation | 1 | 2017 | 9 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 365 | 0.130 |
Why?
| | Rhizotomy | 1 | 2016 | 4 | 0.130 |
Why?
| | Radiography, Interventional | 1 | 2017 | 116 | 0.130 |
Why?
| | Laminectomy | 1 | 2016 | 31 | 0.130 |
Why?
| | Respiratory System | 1 | 2018 | 157 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2018 | 137 | 0.130 |
Why?
| | Quality of Life | 2 | 2018 | 2892 | 0.120 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 195 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3284 | 0.120 |
Why?
| | Continuity of Patient Care | 1 | 2018 | 284 | 0.120 |
Why?
| | Insurance Coverage | 1 | 2017 | 230 | 0.120 |
Why?
| | Electric Impedance | 1 | 2015 | 107 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Bone and Bones | 1 | 2018 | 317 | 0.120 |
Why?
| | Infant | 6 | 2024 | 9465 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5131 | 0.110 |
Why?
| | Range of Motion, Articular | 1 | 2017 | 393 | 0.110 |
Why?
| | Students | 1 | 2020 | 622 | 0.110 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5472 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 322 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2024 | 6079 | 0.110 |
Why?
| | Wheelchairs | 2 | 2015 | 16 | 0.100 |
Why?
| | Siblings | 1 | 2014 | 228 | 0.100 |
Why?
| | Patient Participation | 1 | 2017 | 420 | 0.100 |
Why?
| | Length of Stay | 2 | 2016 | 1215 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 289 | 0.100 |
Why?
| | Mental Health Services | 1 | 2018 | 421 | 0.100 |
Why?
| | Minority Groups | 1 | 2015 | 266 | 0.100 |
Why?
| | Self Care | 1 | 2015 | 380 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2017 | 546 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1483 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 508 | 0.100 |
Why?
| | Muscle Strength | 1 | 2015 | 317 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1147 | 0.100 |
Why?
| | Standard of Care | 1 | 2012 | 72 | 0.090 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.090 |
Why?
| | United States | 7 | 2025 | 14841 | 0.090 |
Why?
| | Clinical Protocols | 1 | 2012 | 271 | 0.080 |
Why?
| | Risk Factors | 4 | 2015 | 10388 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 822 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1329 | 0.080 |
Why?
| | Brain Injuries | 1 | 2015 | 494 | 0.080 |
Why?
| | Vitamin D | 2 | 2015 | 397 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 83 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 13209 | 0.080 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 15 | 0.070 |
Why?
| | Calcium, Dietary | 1 | 2008 | 57 | 0.070 |
Why?
| | Neurologic Examination | 1 | 2008 | 110 | 0.070 |
Why?
| | Mobility Limitation | 1 | 2008 | 61 | 0.070 |
Why?
| | Pilot Projects | 2 | 2025 | 1710 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 2071 | 0.070 |
Why?
| | Adult | 8 | 2025 | 37929 | 0.070 |
Why?
| | Calcium | 2 | 2015 | 1199 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2757 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 2 | 2024 | 565 | 0.060 |
Why?
| | Hospitalization | 1 | 2016 | 2199 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 338 | 0.060 |
Why?
| | Torticollis | 1 | 2005 | 12 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1724 | 0.060 |
Why?
| | Botulinum Toxins, Type A | 1 | 2005 | 45 | 0.060 |
Why?
| | Palliative Care | 1 | 2011 | 758 | 0.060 |
Why?
| | Transition to Adult Care | 1 | 2025 | 91 | 0.050 |
Why?
| | Age Factors | 3 | 2015 | 3295 | 0.050 |
Why?
| | Risk Assessment | 3 | 2017 | 3457 | 0.050 |
Why?
| | Educational Status | 1 | 2024 | 470 | 0.050 |
Why?
| | Incidence | 3 | 2015 | 2804 | 0.050 |
Why?
| | Neonatal Screening | 1 | 2024 | 169 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 5778 | 0.050 |
Why?
| | Pregnenediones | 1 | 2021 | 19 | 0.050 |
Why?
| | Medicaid | 2 | 2017 | 435 | 0.050 |
Why?
| | Prednisolone | 1 | 2021 | 83 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 26 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 180 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 173 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1289 | 0.040 |
Why?
| | Gait | 1 | 2023 | 296 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2023 | 810 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2020 | 154 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1050 | 0.040 |
Why?
| | Knee Joint | 1 | 2023 | 409 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2837 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 4149 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 197 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 806 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 486 | 0.040 |
Why?
| | Health Personnel | 1 | 2024 | 710 | 0.030 |
Why?
| | Nutrition Therapy | 1 | 2018 | 37 | 0.030 |
Why?
| | Internal Fixators | 1 | 2017 | 36 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 956 | 0.030 |
Why?
| | Washington | 1 | 2017 | 156 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2017 | 89 | 0.030 |
Why?
| | Iowa | 1 | 2015 | 30 | 0.030 |
Why?
| | Myography | 1 | 2015 | 7 | 0.030 |
Why?
| | Muscle Strength Dynamometer | 1 | 2015 | 23 | 0.030 |
Why?
| | Arizona | 1 | 2015 | 81 | 0.030 |
Why?
| | Georgia | 1 | 2015 | 86 | 0.030 |
Why?
| | Culturally Competent Care | 1 | 2016 | 63 | 0.030 |
Why?
| | Depression | 1 | 2024 | 1397 | 0.030 |
Why?
| | New York | 1 | 2015 | 126 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2016 | 140 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7604 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 849 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.030 |
Why?
| | Prognosis | 2 | 2014 | 4030 | 0.030 |
Why?
| | Colorado | 2 | 2015 | 4565 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 6828 | 0.020 |
Why?
| | Scoliosis | 1 | 2014 | 215 | 0.020 |
Why?
| | Cognitive Dysfunction | 1 | 2016 | 383 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1357 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2012 | 233 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 2014 | 350 | 0.020 |
Why?
| | Health Status | 1 | 2015 | 792 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2009 | 82 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 98 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 518 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 410 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2016 | 10811 | 0.020 |
Why?
| | Cognition | 1 | 2015 | 1153 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2069 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2005 | 129 | 0.010 |
Why?
| | Middle Aged | 2 | 2020 | 33479 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 786 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2057 | 0.010 |
Why?
|
|
Apkon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|